Literature DB >> 33495275

Biased Effect of Cardiotonic Steroids on Na/K-ATPase-Mediated Signal Transduction.

Yunhui Xu1, Pauline Marck2, Minqi Huang2, Jeffrey X Xie2, Tong Wang2, Joseph I Shapiro2, Liquan Cai2, Feng Feng2, Zijian Xie2.   

Abstract

Recent studies have revealed that Na/K-ATPase (NKA) can transmit signals through ion-pumping-independent activation of pathways relayed by distinct intracellular protein/lipid kinases, and endocytosis challenges the traditional definition that cardiotonic steroids (CTS) are NKA inhibitors. Although additional effects of CTS have long been suspected, revealing its agonist impact through the NKA receptor could be a novel mechanism in understanding the basic biology of NKA. In this study, we tested whether different structural CTS could trigger different sets of NKA/effector interactions, resulting in biased signaling responses without compromising ion-pumping capacity. Using purified NKA, we found that ouabain, digitoxigenin, and somalin cause comparable levels of NKA inhibition. However, although endogenous ouabain stimulates both protein kinases and NKA endocytosis, digitoxigenin and somalin bias to protein kinases and endocytosis, respectively, in LLC-PK1 cells. The positive inotropic effects of CTS are traditionally regarded as NKA inhibitors. However, CTS-induced signaling occurs at concentrations at least one order of magnitude lower than that of inotropy, which eliminates their well known toxic actions on the heart. The current study adds a novel mechanism that CTS could exert its biased signaling properties through the NKA signal transducer. SIGNIFICANCE STATEMENT: Although it is now well accepted that NKA has an ion-pumping-independent signaling function, it is still debated whether direct and conformation-dependent NKA/effector interaction is a key to this function. Therefore, this investigation is significant in advancing our understanding of the basic biology of NKA-mediated signal transduction and gaining molecular insight into the structural elements that are important for cardiotonic steroid's biased action.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33495275      PMCID: PMC7919863          DOI: 10.1124/molpharm.120.000101

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  50 in total

1.  Na(+),K(+)-ATPase isoform selectivity for digitalis-like compounds is determined by two amino acids in the first extracellular loop.

Authors:  Karl M Weigand; Mette Laursen; Herman G P Swarts; Anthonius H J Engwerda; Christian Prüfert; Julia Sandrock; Poul Nissen; Natalya U Fedosova; Frans G M Russel; Jan B Koenderink
Journal:  Chem Res Toxicol       Date:  2014-11-12       Impact factor: 3.739

2.  Quantifying ligand bias at seven-transmembrane receptors.

Authors:  Sudarshan Rajagopal; Seungkirl Ahn; David H Rominger; William Gowen-MacDonald; Christopher M Lam; Scott M Dewire; Jonathan D Violin; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2011-05-24       Impact factor: 4.436

3.  Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases.

Authors:  Michael Haas; Haojie Wang; Jiang Tian; Zijian Xie
Journal:  J Biol Chem       Date:  2002-03-20       Impact factor: 5.157

4.  Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex.

Authors:  Mette Laursen; Jonas Lindholt Gregersen; Laure Yatime; Poul Nissen; Natalya U Fedosova
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

5.  A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension.

Authors:  J M Hamlyn; R Ringel; J Schaeffer; P D Levinson; B P Hamilton; A A Kowarski; M P Blaustein
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

Review 6.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

7.  Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.

Authors:  A Yoda; S Yoda
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

8.  Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.

Authors:  A Yoda; S Yoda
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

9.  Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism.

Authors:  Jiang Liu; Riad Kesiry; Sankaridrug M Periyasamy; Deepak Malhotra; Zijian Xie; Joseph I Shapiro
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

10.  Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease.

Authors:  Christopher A Drummond; Xiaoming Fan; Steven T Haller; David J Kennedy; Jiang Liu; Jiang Tian
Journal:  PLoS One       Date:  2018-05-18       Impact factor: 3.240

View more
  2 in total

Review 1.  Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome.

Authors:  Carolina Castillo-Castro; Alexandro José Martagón-Rosado; Rocio Ortiz-Lopez; Luis Felipe Garrido-Treviño; Melissa Villegas-Albo; Francisco Javier Bosques-Padilla
Journal:  World J Hepatol       Date:  2021-11-27

2.  Short-Term Mild Hypoxia Modulates Na,K-ATPase to Maintain Membrane Electrogenesis in Rat Skeletal Muscle.

Authors:  Violetta V Kravtsova; Arina A Fedorova; Maria V Tishkova; Alexandra A Livanova; Viacheslav O Matytsin; Viacheslav P Ganapolsky; Oleg V Vetrovoy; Igor I Krivoi
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.